J Ackermann

602 total citations
17 papers, 445 citations indexed

About

J Ackermann is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, J Ackermann has authored 17 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 10 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in J Ackermann's work include Multiple Myeloma Research and Treatments (12 papers), Peptidase Inhibition and Analysis (5 papers) and Glycosylation and Glycoproteins Research (4 papers). J Ackermann is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Peptidase Inhibition and Analysis (5 papers) and Glycosylation and Glycoproteins Research (4 papers). J Ackermann collaborates with scholars based in Austria and Germany. J Ackermann's co-authors include Johannes Drach, H. Kaufmann, Niklas Zojer, Heinz Gisslinger, Christoph Zielinski, Verena Sagaster, Heinz Ludwig, Rotraud Wieser, H. Huber and Klaus Lechner and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and Leukemia.

In The Last Decade

J Ackermann

17 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Ackermann Austria 12 287 280 185 87 85 17 445
Naozo Nakazawa Japan 8 230 0.8× 238 0.8× 94 0.5× 89 1.0× 52 0.6× 11 361
Christian Hurtz United States 10 258 0.9× 246 0.9× 115 0.6× 107 1.2× 47 0.6× 32 607
María T. Ardañaz Spain 7 188 0.7× 166 0.6× 69 0.4× 130 1.5× 54 0.6× 9 324
Yoshiaki Chinen Japan 14 170 0.6× 291 1.0× 143 0.8× 58 0.7× 134 1.6× 49 513
Axelle Daviet France 9 523 1.8× 411 1.5× 185 1.0× 240 2.8× 103 1.2× 10 651
D Borrego Spain 7 342 1.2× 186 0.7× 155 0.8× 105 1.2× 47 0.6× 11 414
T Kinoshita Japan 10 133 0.5× 198 0.7× 205 1.1× 107 1.2× 104 1.2× 17 437
Donata Verdelli Italy 10 346 1.2× 398 1.4× 145 0.8× 61 0.7× 75 0.9× 14 532
N Smadja France 9 332 1.2× 243 0.9× 104 0.6× 124 1.4× 33 0.4× 17 440
Nicole Duclos United States 8 323 1.1× 326 1.2× 84 0.5× 161 1.9× 22 0.3× 9 551

Countries citing papers authored by J Ackermann

Since Specialization
Citations

This map shows the geographic impact of J Ackermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Ackermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Ackermann more than expected).

Fields of papers citing papers by J Ackermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Ackermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Ackermann. The network helps show where J Ackermann may publish in the future.

Co-authorship network of co-authors of J Ackermann

This figure shows the co-authorship network connecting the top 25 collaborators of J Ackermann. A scholar is included among the top collaborators of J Ackermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Ackermann. J Ackermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kaufmann, H., J Ackermann, Verena Sagaster, et al.. (2007). Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS. European Journal of Clinical Investigation. 38(1). 53–60. 3 indexed citations
2.
Sagaster, Verena, H. Kaufmann, J Ackermann, et al.. (2006). Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System. European Journal Of Haematology. 78(3). 227–234. 13 indexed citations
3.
Sagaster, Verena, Heinz Ludwig, H. Kaufmann, et al.. (2006). Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion. Leukemia. 21(1). 164–168. 86 indexed citations
4.
5.
Häuser, I, German Ott, Johannes Drach, et al.. (2003). Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome. Leukemia. 18(1). 146–155. 42 indexed citations
6.
Kaufmann, H., J Ackermann, Hildegard Greinix, et al.. (2003). Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic features. Annals of Oncology. 14(11). 1667–1672. 2 indexed citations
7.
Drach, Johannes, et al.. (2003). Low Dose Thalidomide in Patients with Relapsed or Refractory Multiple Myeloma. Leukemia & lymphoma. 44(11). 1943–1946. 11 indexed citations
8.
Worel, Nina, Hildegard Greinix, J Ackermann, et al.. (2001). Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma. Annals of Hematology. 80(6). 345–348. 23 indexed citations
9.
Kaufmann, H., et al.. (2001). Advances in the biology and therapeutic management of multiple myeloma. Annals of Hematology. 80(8). 445–451. 13 indexed citations
10.
Kaufmann, H., J Ackermann, Niklas Zojer, et al.. (2001). Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma - a report on two cases. Annals of Hematology. 80(8). 474–478. 28 indexed citations
11.
12.
Königsberg, Robert, J Ackermann, H. Kaufmann, et al.. (2000). Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance. Leukemia. 14(11). 1975–1979. 55 indexed citations
13.
Filipits, Martin, Johannes Drach, Gudrun Pohl, et al.. (1999). Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.. PubMed. 5(9). 2426–30. 39 indexed citations
14.
Keil, Felix, Peter Kalhs, Oskar A. Haas, et al.. (1999). Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation. Annals of Hematology. 78(8). 376–379. 9 indexed citations
15.
Pirc‐Danoewinata, Hendrati, J Ackermann, Johannes Drach, et al.. (1998). Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization. British Journal of Cancer. 79(1). 131–137. 8 indexed citations
16.
Schwarzmeier, Josef D., Sabine Walchshofer, Niklas Zojer, et al.. (1998). A case of bone marrow mastocytosis associated with multiple myeloma. Annals of Hematology. 76(3-4). 167–174. 27 indexed citations
17.
Zojer, Niklas, Michael Fiegl, Leonhard Müllauer, et al.. (1998). Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects. British Journal of Cancer. 77(8). 1337–1342. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naozo Nakazawa Breakdown of academic impact, for papers by Christian Hurtz Breakdown of academic impact, for papers by María T. Ardañaz Breakdown of academic impact, for papers by Yoshiaki Chinen Breakdown of academic impact, for papers by Axelle Daviet Breakdown of academic impact, for papers by D Borrego Breakdown of academic impact, for papers by T Kinoshita Breakdown of academic impact, for papers by Donata Verdelli Breakdown of academic impact, for papers by N Smadja Breakdown of academic impact, for papers by Nicole Duclos
Rankless by CCL
2026